Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. | |||
Founding Date | Founding Date N/A | Founding Date 1996 | Founding Date 2021 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Poitiers, FR HQ | Locations South San Francisco, US HQ | Locations Johnson City, US HQ |
Employees | Employees N/A | Employees 1633% increase | Employees 7 |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 130m | Total funding raised $ 5m |
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
View company
Bryleos (also known as BioNADrx Holdings) is a clinical stage therapeutics company.
View company